Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Ischemic Heart Disease

  Free Subscription


26.08.2019

2 Am Heart J
6 Am J Cardiol
1 Am J Med
1 Angiology
1 Ann Intern Med
1 Ann Thorac Surg
2 Arterioscler Thromb Vasc Biol
1 Atherosclerosis
1 BMJ
2 Catheter Cardiovasc Interv
4 Circ Cardiovasc Interv
1 Circ Heart Fail
10 Circulation
1 Int J Cardiol
6 J Am Coll Cardiol
1 J Cardiovasc Pharmacol
1 J Thorac Cardiovasc Surg
3 JAMA
2 Lancet Diabetes Endocrinol
1 Prog Cardiovasc Dis
3 Thromb Haemost


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am Heart J

  1. OKEKE NL, Webel AR, Bosworth HB, Aifah A, et al
    Rationale and design of a nurse-led intervention to extend the HIV treatment cascade for cardiovascular disease prevention trial (EXTRA-CVD).
    Am Heart J. 2019;216:91-101.
    PubMed     Text format     Abstract available

  2. DECKER PA, Larson NB, Bell EJ, Pankow JS, et al
    Erratum to "Increased hepatocyte growth factor levels over 2 years are associated with coronary heart disease: The Multi-Ethnic Study of Atherosclerosis (MESA)" [Am Heart J (2019) 30-34].
    Am Heart J. 2019 Aug 19. pii: S0002-8703(19)30176.
    PubMed     Text format    


    Am J Cardiol

  3. NASSAR M, Arow Z, Monakier D, Zusman O, et al
    Effect of Intramural Course of Coronary Arteries Assessed by Computed Tomography Angiography in Patients With Hypertrophic Cardiomyopathy.
    Am J Cardiol. 2019 Jul 29. pii: S0002-9149(19)30824.
    PubMed     Text format     Abstract available

  4. ARPS K, Rifai MA, Blaha MJ, Michos ED, et al
    Usefulness of Coronary Artery Calcium to Identify Adults of Sufficiently High Risk for Atherothrombotic Cardiovascular Events to Consider Low-Dose Rivaroxaban Thromboprophylaxis (from MESA).
    Am J Cardiol. 2019 Jul 24. pii: S0002-9149(19)30813.
    PubMed     Text format     Abstract available

  5. KWOK CS, Lundberg G, Al-Faleh H, Sirker A, et al
    Relation of Frailty to Outcomes in Patients With Acute Coronary Syndromes.
    Am J Cardiol. 2019 Jul 26. pii: S0002-9149(19)30763.
    PubMed     Text format     Abstract available

  6. ELLIS SG, Cho L, Raymond R, Nair R, et al
    Comparison of Long-Term Clinical Outcomes After Drug-Eluting Stenting in Blacks-vs-Whites.
    Am J Cardiol. 2019 Jul 25. pii: S0002-9149(19)30817.
    PubMed     Text format     Abstract available

  7. RAKOWSKI T, Wegiel M, Siudak Z, Plens K, et al
    Prevalence and Predictors of Coronary Artery Perforation During Percutaneous Coronary Interventions (from the ORPKI National Registry in Poland).
    Am J Cardiol. 2019 Jul 25. pii: S0002-9149(19)30818.
    PubMed     Text format     Abstract available

  8. NICHOLS GA, Philip S, Reynolds K, Granowitz CB, et al
    Comparison of Medical Care Utilization and Costs Among Patients With Statin-Controlled Low-Density Lipoprotein Cholesterol With Versus Without Hypertriglyceridemia.
    Am J Cardiol. 2018 Jul 5. pii: S0002-9149(18)31321.
    PubMed     Text format     Abstract available


    Am J Med

  9. MARCINIAK TA, Atar D, Serebruany V
    Does Ivabradine Decrease Cardiovascular Deaths in Heart Failure Patients?
    Am J Med. 2019 Aug 20. pii: S0002-9343(19)30691.
    PubMed     Text format     Abstract available


    Angiology

  10. ERMIS E, Yildirim E, Ucar H, Allahverdiyev S, et al
    The Association Between SYNTAX Score II and Carotid Artery Disease Severity in Patients Who Underwent Coronary Artery Bypass Grafting.
    Angiology. 2019 Aug 15:3319719868360. doi: 10.1177/0003319719868360.
    PubMed     Text format     Abstract available


    Ann Intern Med

  11. HUDSON MP
    Coronary CTA reduced risk for coronary events at 5 years in patients with stable chest pain.
    Ann Intern Med. 2018;169:JC70.
    PubMed     Text format    


    Ann Thorac Surg

  12. BIANCARI F, Santini F, Tauriainen T, Bancone C, et al
    Epiaortic Ultrasound to Prevent Stroke in Coronary Artery Bypass Grafting.
    Ann Thorac Surg. 2019 Aug 14. pii: S0003-4975(19)31181.
    PubMed     Text format     Abstract available


    Arterioscler Thromb Vasc Biol

  13. KEVIL CG, Goeders NE, Woolard MD, Bhuiyan MS, et al
    Methamphetamine Use and Cardiovascular Disease.
    Arterioscler Thromb Vasc Biol. 2019;39:1739-1746.
    PubMed     Text format     Abstract available

  14. LI F, Shi J, Lu HS, Zhang H, et al
    Functional Genomics and CRISPR Applied to Cardiovascular Research and Medicine.
    Arterioscler Thromb Vasc Biol. 2019;39:e188-e194.
    PubMed     Text format    


    Atherosclerosis

  15. VELLE-FORBORD T, Eidlaug M, Debik J, Saether JC, et al
    Circulating microRNAs as predictive biomarkers of myocardial infarction: Evidence from the HUNT study.
    Atherosclerosis. 2019;289:1-7.
    PubMed     Text format     Abstract available


    BMJ

  16. DIJK S, Lok P
    Polypill cuts major cardiovascular events by a third, study finds.
    BMJ. 2019;366:l5268.
    PubMed     Text format    


    Catheter Cardiovasc Interv

  17. KIM YH, Her AY, Jeong MH, Kim BK, et al
    Impact of stent generation on 2-year clinical outcomes in ST-segment elevation myocardial infarction patients with multivessel disease who underwent culprit-only or multivessel percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2019 Aug 18. doi: 10.1002/ccd.28440.
    PubMed     Text format     Abstract available

  18. MARQUIS-GRAVEL G, Zeitouni M, Kochar A, Jones WS, et al
    Technical consideration in acute myocardial infarction with cardiogenic shock: A review of antithrombotic and PCI therapies.
    Catheter Cardiovasc Interv. 2019 Aug 21. doi: 10.1002/ccd.28455.
    PubMed     Text format     Abstract available


    Circ Cardiovasc Interv

  19. HOLMES DR JR, Barsness GW
    Percutaneous Coronary Intervention for Chronic Total Occlusions.
    Circ Cardiovasc Interv. 2019;12:e008321.
    PubMed     Text format    

  20. DALGAARD F, Jones WS, Piccini JP
    Atrial Fibrillation and Percutaneous Coronary Intervention.
    Circ Cardiovasc Interv. 2019;12:e008269.
    PubMed     Text format    

  21. OLIVIER CB, Fan J, Askari M, Mahaffey KW, et al
    Site Variation and Outcomes for Antithrombotic Therapy in Atrial Fibrillation Patients After Percutaneous Coronary Intervention.
    Circ Cardiovasc Interv. 2019;12:e007604.
    PubMed     Text format     Abstract available

  22. YOUNG MN, Secemsky EA, Kaltenbach LA, Jaffer FA, et al
    Examining the Operator Learning Curve for Percutaneous Coronary Intervention of Chronic Total Occlusions.
    Circ Cardiovasc Interv. 2019;12:e007877.
    PubMed     Text format     Abstract available


    Circ Heart Fail

  23. SYMONS JD, Deeter L, Deeter N, Bonn T, et al
    Effect of Continuous-Flow Left Ventricular Assist Device Support on Coronary Artery Endothelial Function in Ischemic and Nonischemic Cardiomyopathy.
    Circ Heart Fail. 2019;12:e006085.
    PubMed     Text format     Abstract available


    Circulation

  24. LARSSON SC, Markus HS
    Genetic Liability to Insomnia and Cardiovascular Disease Risk.
    Circulation. 2019 Aug 19. doi: 10.1161/CIRCULATIONAHA.119.041830.
    PubMed     Text format    

  25. ZEKI AL HAZZOURI A, Elfassy T, Glymour MM
    Response by Zeki Al Hazzouri et al to Letter Regarding Article, "Associations of Income Volatility With Incident Cardiovascular Disease and All-Cause Mortality in a US Cohort: 1990 to 2015".
    Circulation. 2019;140:e327-e328.
    PubMed     Text format    

  26. SHAKIBA M, Mansournia MA
    Letter by Shakiba and Mansournia Regarding Article, "Associations of Income Volatility With Incident Cardiovascular Disease and All-Cause Mortality in a US Cohort: 1990 to 2015".
    Circulation. 2019;140:e325-e326.
    PubMed     Text format    

  27. OUCHI Y, Sasaki J, Arai H, Yokote K, et al
    Ezetimibe Lipid-Lowering Trial on Prevention of Atherosclerotic Cardiovascular Disease in 75 or Older (EWTOPIA 75): A Randomized Controlled Trial.
    Circulation. 2019 Aug 22. doi: 10.1161/CIRCULATIONAHA.118.039415.
    PubMed     Text format     Abstract available

  28. VERMA S, Mazer CD, Yan AT, Mason T, et al
    Effect of Empagliflozin on Left Ventricular Mass in Patients with Type 2 Diabetes and Coronary Artery Disease: The EMPA-HEART CardioLink-6 Randomized Clinical Trial.
    Circulation. 2019 Aug 22. doi: 10.1161/CIRCULATIONAHA.119.042375.
    PubMed     Text format     Abstract available

  29. THAN MP, Pickering JW, Sandoval Y, Shah ASV, et al
    Machine Learning to Predict the Likelihood of Acute Myocardial Infarction.
    Circulation. 2019 Aug 16. doi: 10.1161/CIRCULATIONAHA.119.041980.
    PubMed     Text format     Abstract available

  30. DEFILIPPIS AP, Chapman AR, Mills NL, de Lemos JA, et al
    Assessment and Treatment of Patients with Type 2 Myocardial Infarction and Acute Non-Ischemic Myocardial Injury.
    Circulation. 2019 Aug 16. doi: 10.1161/CIRCULATIONAHA.119.040631.
    PubMed     Text format     Abstract available

  31. ARORA S, Rosamond WD, Caughey MC
    Response by Arora et al to Letter Regarding Article, "Twenty Year Trends and Sex Differences in Young Adults Hospitalized With Acute Myocardial Infarction: The ARIC Community Surveillance Study".
    Circulation. 2019;140:e331-e332.
    PubMed     Text format    

  32. AGHA G, Mendelson MM, Ward-Caviness CK, Joehanes R, et al
    Blood Leukocyte DNA Methylation Predicts Risk of Future Myocardial Infarction and Coronary Heart Disease.
    Circulation. 2019;140:645-657.
    PubMed     Text format     Abstract available

  33. ZHANG S, Zhuang X, Liao X
    Letter by Zhang et al Regarding Article, "Twenty Year Trends and Sex Differences in Young Adults Hospitalized With Acute Myocardial Infarction: The ARIC Community Surveillance Study".
    Circulation. 2019;140:e329-e330.
    PubMed     Text format    


    Int J Cardiol

  34. ZHAO L, Zheng M, Guo Z, Li K, et al
    Circulating Serpina3 levels predict the major adverse cardiac events in patients with myocardial infarction.
    Int J Cardiol. 2019 Aug 15. pii: S0167-5273(19)33203.
    PubMed     Text format     Abstract available


    J Am Coll Cardiol

  35. CEDIEL G, Bardaji A, Barrabes JA
    Ruling Out Acute Coronary Syndromes: Troponin Is Essential, as Is Clinical Assessment.
    J Am Coll Cardiol. 2019;74:855-857.
    PubMed     Text format    

  36. QAMAR A, Giugliano RP, Bohula EA, Park JG, et al
    Biomarkers and Clinical Cardiovascular Outcomes With Ezetimibe in the IMPROVE-IT Trial.
    J Am Coll Cardiol. 2019;74:1057-1068.
    PubMed     Text format     Abstract available

  37. MORAES G, Kovacs RJ
    Building Bridges Between ACC and Women's Cardiovascular Health Around the World.
    J Am Coll Cardiol. 2019;74:1156-1158.
    PubMed     Text format    

  38. COLLET C, Miyazaki Y, Ryan N, Asano T, et al
    Fractional Flow Reserve Derived From Computed Tomographic Angiography in Patients With Multivessel CAD.
    J Am Coll Cardiol. 2018 Apr 17. pii: S0735-1097(18)33492.
    PubMed     Text format     Abstract available

  39. OBOKATA M, Reddy YNV, Melenovsky V, Kane GC, et al
    Myocardial Injury and Cardiac Reserve in Patients With Heart Failure and Preserved Ejection Fraction.
    J Am Coll Cardiol. 2018;72:29-40.
    PubMed     Text format     Abstract available

  40. NESTELBERGER T, Boeddinghaus J, Wussler D, Twerenbold R, et al
    Predicting Major Adverse Events in Patients With Acute Myocardial Infarction.
    J Am Coll Cardiol. 2019;74:842-854.
    PubMed     Text format     Abstract available


    J Cardiovasc Pharmacol

  41. ZHANG J, Pan J, Yang M, Jin X, et al
    Up-regulating microRNA-203 alleviates myocardial remodeling and cell apoptosis through down-regulating PTP1B in rats with myocardial infarction.
    J Cardiovasc Pharmacol. 2019 Aug 10. doi: 10.1097/FJC.0000000000000733.
    PubMed     Text format     Abstract available


    J Thorac Cardiovasc Surg

  42. GAIPOV A, Molnar MZ, Potukuchi PK, Sumida K, et al
    Predialysis coronary revascularization and postdialysis mortality.
    J Thorac Cardiovasc Surg. 2019;157:976-983.
    PubMed     Text format     Abstract available


    JAMA

  43. DUNCAN MS, Freiberg MS, Greevy RA Jr, Kundu S, et al
    Association of Smoking Cessation With Subsequent Risk of Cardiovascular Disease.
    JAMA. 2019;322:642-650.
    PubMed     Text format     Abstract available

  44. COLE TB
    Smoking Cessation and Reduction of Cardiovascular Disease Risk.
    JAMA. 2019;322:651.
    PubMed     Text format    

  45. GREGG EW, Hora I, Benoit SR
    Resurgence in Diabetes-Related Complications.
    JAMA. 2019 Apr 15. pii: 2730953. doi: 10.1001/jama.2019.3471.
    PubMed     Text format    


    Lancet Diabetes Endocrinol

  46. KRISTENSEN SL, Rorth R, Jhund PS, Docherty KF, et al
    Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials.
    Lancet Diabetes Endocrinol. 2019 Aug 14. pii: S2213-8587(19)30249.
    PubMed     Text format     Abstract available

  47. STANDL E
    GLP-1 receptor agonists and cardiovascular outcomes: an updated synthesis.
    Lancet Diabetes Endocrinol. 2019 Aug 14. pii: S2213-8587(19)30267.
    PubMed     Text format    


    Prog Cardiovasc Dis

  48. ACHARYA T, Deedwania P
    Cardiovascular outcome trials of the newer anti-diabetic medications.
    Prog Cardiovasc Dis. 2019 Aug 20. pii: S0033-0620(19)30106.
    PubMed     Text format     Abstract available


    Thromb Haemost

  49. STOJKOVIC S, Nossent AY, Haller P, Jager B, et al
    MicroRNAs as Regulators and Biomarkers of Platelet Function and Activity in Coronary Artery Disease.
    Thromb Haemost. 2019 Aug 17. doi: 10.1055/s-0039-1693702.
    PubMed     Text format     Abstract available

  50. PATTI G, Di Martino G, Ricci F, Renda G, et al
    Platelet Indices and Risk of Death and Cardiovascular Events: Results from a Large Population-Based Cohort Study.
    Thromb Haemost. 2019 Aug 20. doi: 10.1055/s-0039-1694969.
    PubMed     Text format     Abstract available

  51. ADATIA K, Farag MF, Gue YX, Srinivasan M, et al
    Relationship of Platelet Reactivity and Inflammatory Markers to Recurrent Adverse Events in Patients with ST-Elevation Myocardial Infarction.
    Thromb Haemost. 2019 Aug 22. doi: 10.1055/s-0039-1695007.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: